LIFETECH SCI.DL-00000125 (81X) — Capital Reinvestment Ratio
Latest as of December 2025:
0.27x
LIFETECH SCI.DL-00000125 (81X) has a Capital Reinvestment Ratio of 0.27x as of December 2025, meaning it reinvests 0% of its operating cash flow (€549.28 Million) in capital expenditures (€150.25 Million). See 81X free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.27x
Capex / Operating Cash Flow
Operating Cash Flow
€549.28 Million
EUR
Capital Expenditures
€150.25 Million
EUR
Data as of
Dec 2025
Most recent filing
LIFETECH SCI.DL-00000125 Capital Reinvestment Ratio (2021–2025)
This chart tracks LIFETECH SCI.DL-00000125's Capital Reinvestment Ratio across 5 annual periods.
Annual Capital Reinvestment Ratio for LIFETECH SCI.DL-00000125 (2021–2025)
Year-by-year Capital Reinvestment Ratio for LIFETECH SCI.DL-00000125 from 2021 to 2025. For live market cap and broader valuation context, see how much is LIFETECH SCI.DL-00000125 worth.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.27x | €549.28 Million | €150.25 Million | ▼ -68.9% |
| 2024 | 0.88x | €321.46 Million | €283.00 Million | ▲ +25.7% |
| 2023 | 0.70x | €418.05 Million | €292.69 Million | ▼ -19.0% |
| 2022 | 0.86x | €388.32 Million | €335.47 Million | ▲ +11.0% |
| 2021 | 0.78x | €441.09 Million | €343.29 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow